DOCSLIB.ORG

Mouse Carmil1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Carmil1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Carmil1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Carmil1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Carmil1 gene (NCBI Reference Sequence: NM_026825.3 ; Ensembl: ENSMUSG00000021338 ) is located on Mouse chromosome 13. 38 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 38 (Transcript: ENSMUST00000072889). Exon 5 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Carmil1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-75N16 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: No abnormal phenotype was observed in a high-throughput screen, nor in a pathology assessment. Exon 5 starts from about 6.07% of the coding region. The knockout of Exon 5 will result in frameshift of the gene. The size of intron 4 for 5'-loxP site insertion: 8693 bp, and the size of intron 5 for 3'-loxP site insertion: 9313 bp. The size of effective cKO region: ~622 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 5 38 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Carmil1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7122bp) | A(24.4% 1738) | C(23.2% 1652) | T(31.14% 2218) | G(21.26% 1514) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr13 - 24165173 24168172 3000 browser details YourSeq 100 1488 1611 3000 91.4% chr18 - 60460851 60460975 125 browser details YourSeq 88 1460 1569 3000 85.3% chr13 + 81049513 81049607 95 browser details YourSeq 85 1460 1566 3000 84.8% chr5 - 133723790 133723881 92 browser details YourSeq 85 1460 1569 3000 84.3% chr17 + 79212468 79212565 98 browser details YourSeq 85 1460 1566 3000 87.4% chr12 + 14278957 14279056 100 browser details YourSeq 84 1462 1566 3000 89.4% chr2 - 12691652 12691754 103 browser details YourSeq 84 1487 1761 3000 92.0% chr18 - 56681436 56681729 294 browser details YourSeq 81 1468 1566 3000 85.4% chr14 - 46062188 46062277 90 browser details YourSeq 77 1460 1552 3000 85.6% chrX - 12032679 12032762 84 browser details YourSeq 76 1463 1552 3000 89.1% chr5 - 14202775 14202859 85 browser details YourSeq 73 1484 1569 3000 94.1% chrX - 157127454 157127539 86 browser details YourSeq 73 1461 1545 3000 85.8% chr8 + 29541300 29541376 77 browser details YourSeq 69 1460 1540 3000 85.0% chrX + 83226657 83226729 73 browser details YourSeq 69 1460 1559 3000 85.9% chr10 + 44131593 44131685 93 browser details YourSeq 68 1460 1552 3000 84.9% chr14 - 78472826 78472911 86 browser details YourSeq 68 1491 1566 3000 92.0% chr6 + 106405777 106405851 75 browser details YourSeq 64 1490 1566 3000 88.6% chr3 - 45279089 45279161 73 browser details YourSeq 58 1575 1712 3000 95.4% chr16 + 90516251 90516624 374 browser details YourSeq 30 1736 1769 3000 94.2% chr4 + 12387345 12387378 34 Note: The 3000 bp section upstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr13 - 24161551 24164550 3000 browser details YourSeq 78 2241 2539 3000 77.9% chr7 - 119675286 119675503 218 browser details YourSeq 78 2432 2656 3000 68.1% chr5 + 43588544 43588701 158 browser details YourSeq 74 2439 2704 3000 70.0% chr18 + 20467584 20467740 157 browser details YourSeq 72 2447 2647 3000 71.0% chr8 - 33989546 33989703 158 browser details YourSeq 68 2432 2654 3000 70.3% chr16 - 33157709 33157910 202 browser details YourSeq 62 2423 2534 3000 77.7% chr14 + 54366132 54366243 112 browser details YourSeq 62 2432 2653 3000 78.1% chr11 + 35555284 35555482 199 browser details YourSeq 62 2423 2534 3000 77.7% chr10 + 92972141 92972252 112 browser details YourSeq 61 2455 2731 3000 67.4% chr6 - 52627455 52627653 199 browser details YourSeq 59 2438 2534 3000 80.5% chr5 - 110586870 110586966 97 browser details YourSeq 59 2452 2546 3000 81.1% chr5 + 90489651 90489745 95 browser details YourSeq 58 2427 2677 3000 73.3% chr11 + 97461861 97462289 429 browser details YourSeq 57 2453 2589 3000 77.7% chr12 - 107944993 107945417 425 browser details YourSeq 57 2432 2534 3000 77.7% chr11 + 57699833 57699935 103 browser details YourSeq 56 2432 2534 3000 78.0% chr2 - 49504824 49504927 104 browser details YourSeq 56 2432 2513 3000 84.2% chr14 + 46866561 46866642 82 browser details YourSeq 55 2432 2723 3000 67.7% chr10 + 40337866 40338018 153 browser details YourSeq 54 2438 2535 3000 87.4% chr11 + 102803177 103191327 388151 browser details YourSeq 53 2436 2530 3000 77.9% chr9 + 123646616 123646710 95 Note: The 3000 bp section downstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Carmil1 capping protein regulator and myosin 1 linker 1 [ Mus musculus (house mouse) ] Gene ID: 68732, updated on 26-Jun-2020 Gene summary Official Symbol Carmil1 provided by MGI Official Full Name capping protein regulator and myosin 1 linker 1 provided by MGI Primary source MGI:MGI:1915982 See related Ensembl:ENSMUSG00000021338 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as CARMIL; CARML1; Lrrc16; Lrrc16a; AI425970; D130057M20; 1110037D04Rik Expression Ubiquitous expression in testis adult (RPKM 3.6), CNS E18 (RPKM 3.4) and 28 other tissues See more Orthologs human all Genomic context Location: 13; 13 A3.1 See Carmil1 in Genome Data Viewer Exon count: 42 Annotation release Status Assembly Chr Location 108.20200622 current GRCm38.p6 (GCF_000001635.26) 13 NC_000079.6 (24012481..24280802, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 13 NC_000079.5 (24104353..24372659, complement) Chromosome 13 - NC_000079.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 12 transcripts Gene: Carmil1 ENSMUSG00000021338 Description capping protein regulator and myosin 1 linker 1 [Source:MGI Symbol;Acc:MGI:1915982] Gene Synonyms 1110037D04Rik, Carmil, Lrrc16, Lrrc16a Location Chromosome 13: 24,012,344-24,280,795 reverse strand. GRCm38:CM001006.2 About this gene This gene has 12 transcripts (splice variants), 343 orthologues, 4 paralogues, is a member of 1 Ensembl protein family and is associated with 1 phenotype. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Carmil1- ENSMUST00000072889.11 4988 1374aa ENSMUSP00000072662.5 Protein coding CCDS36621 Q6EDY6 TSL:1 201 GENCODE basic APPRIS P3 Carmil1- ENSMUST00000110398.7 4520 1332aa ENSMUSP00000106028.2 Protein coding CCDS79171 D3Z030 TSL:1 202 GENCODE basic APPRIS ALT2 Carmil1- ENSMUST00000151566.1 1185 173aa ENSMUSP00000120971.1 Protein coding - F6XQY1 CDS 5' 212 incomplete TSL:1 Carmil1- ENSMUST00000140042.7 580 57aa ENSMUSP00000127121.1 Protein coding - E9Q4H6 CDS 3' 208 incomplete TSL:3 Carmil1- ENSMUST00000123076.7 428 20aa ENSMUSP00000130100.1 Protein coding - E9Q7X4 CDS 3' 203 incomplete TSL:3 Carmil1- ENSMUST00000125901.7 4071 932aa ENSMUSP00000126522.1 Nonsense mediated - F7AI27 CDS 5' 205 decay incomplete TSL:1 Carmil1- ENSMUST00000147261.1 645 No - Processed transcript - - TSL:5 211 protein Carmil1- ENSMUST00000144159.1 394 No - Processed transcript - - TSL:5 210 protein Carmil1- ENSMUST00000136517.1 311 No - Processed transcript - - TSL:3 207 protein Carmil1- ENSMUST00000128416.1 215 No - Processed transcript - - TSL:5 206 protein Carmil1- ENSMUST00000125420.7 2501 No - Retained intron - - TSL:1 204 protein Carmil1- ENSMUST00000142171.1 2350 No - Retained intron - - TSL:1 209 protein Page 6 of 8 https://www.alphaknockout.com 288.45 kb Forward strand 24.05Mb 24.10Mb 24.15Mb 24.20Mb 24.25Mb Genes Gm11343-201 >processed pseudogene (Comprehensive set... Contigs AL606464.11 > AL683873.14 > AL590864.12 > Genes (Comprehensive set... < Carmil1-205nonsense mediated decay < Carmil1-204retained intron < Carmil1-212protein coding < Carmil1-209retained intron< Carmil1-206processed transcript < Carmil1-203protein
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells
    Corrected: Author correction; Author correction ARTICLE https://doi.org/10.1038/s41467-019-09614-y OPEN Gene correction for SCID-X1 in long-term hematopoietic stem cells Mara Pavel-Dinu1, Volker Wiebking 1, Beruh T. Dejene1, Waracharee Srifa1, Sruthi Mantri1, Carmencita E. Nicolas1, Ciaran Lee 2, Gang Bao2, Eric J. Kildebeck3, Niraj Punjya1,6, Camille Sindhu1, Matthew A. Inlay4, Nivedita Saxena1, Suk See DeRavin5, Harry Malech5, Maria Grazia Roncarolo1, Kenneth I. Weinberg1 & Matthew H. Porteus 1 1234567890():,; Gene correction in human long-term hematopoietic stem cells (LT-HSCs) could be an effective therapy for monogenic diseases of the blood and immune system. Here we describe an approach for X-linked sSevere cCombined iImmunodeficiency (SCID-X1) using targeted integration of a cDNA into the endogenous start codon to functionally correct disease- causing mutations throughout the gene. Using a CRISPR-Cas9/AAV6 based strategy, we achieve up to 20% targeted integration frequencies in LT-HSCs. As measures of the lack of toxicity we observe no evidence of abnormal hematopoiesis following transplantation and no evidence of off-target mutations using a high-fidelity Cas9 as a ribonucleoprotein complex. We achieve high levels of targeting frequencies (median 45%) in CD34+ HSPCs from six SCID-X1 patients and demonstrate rescue of lymphopoietic defect in a patient derived HSPC population in vitro and in vivo. In sum, our study provides specificity, toxicity and efficacy data supportive of clinical development of genome editing to treat SCID-Xl. 1 Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. 2 Department of Bioengineering, Rice University, Houston, TX 77030, USA.
    [Show full text]
  • Final Copy 2019 10 01 Hawo
    This electronic thesis or dissertation has been downloaded from Explore Bristol Research, http://research-information.bristol.ac.uk Author: Haworth, Simon Title: The use of genetic data in dental epidemiology to explore the causes and consequences of caries and periodontitis General rights Access to the thesis is subject to the Creative Commons Attribution - NonCommercial-No Derivatives 4.0 International Public License. A copy of this may be found at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode This license sets out your rights and the restrictions that apply to your access to the thesis so it is important you read this before proceeding. Take down policy Some pages of this thesis may have been removed for copyright restrictions prior to having it been deposited in Explore Bristol Research. However, if you have discovered material within the thesis that you consider to be unlawful e.g. breaches of copyright (either yours or that of a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, libel, then please contact [email protected] and include the following information in your message: •Your contact details •Bibliographic details for the item, including a URL •An outline nature of the complaint Your claim will be investigated and, where appropriate, the item in question will be removed from public view as soon as possible. The use of genetic data in dental epidemiology to explore the causes and consequences of caries and periodontitis Simon Haworth A dissertation submitted to the University of Bristol in accordance with the requirements for award of the degree of PhD in the Faculty of Health Sciences, September 2019 Word count: 77,472 words 1 Abstract The major dental diseases are caries and periodontitis.
    [Show full text]
  • GWAS for Meat and Carcass Traits Using Imputed Sequence Level Genotypes in Pooled F2-Designs in Pigs
    INVESTIGATION GWAS for Meat and Carcass Traits Using Imputed Sequence Level Genotypes in Pooled F2-Designs in Pigs Clemens Falker-Gieske,*,1,2 Iulia Blaj,†,2 Siegfried Preuß,‡ Jörn Bennewitz,‡ Georg Thaller,† and Jens Tetens*,§ *Department of Animal Sciences, Georg-August-University, 37077 Göttingen, Germany, †Institute of Animal Breeding and Husbandry, Kiel University, 24118 Kiel, Germany, ‡Institute of Animal Husbandry and Breeding, University of § Hohenheim, 70599 Stuttgart, Germany, and Center for Integrated Breeding Research, Georg-August-University, 37077 Göttingen, Germany ORCID IDs: 0000-0001-9160-1909 (C.F.-G.); 0000-0002-8744-3415 (I.B.); 0000-0002-6782-2039 (G.T.); 0000-0001-5352-464X (J.T.) ABSTRACT In order to gain insight into the genetic architecture of economically important traits in pigs KEYWORDS and to derive suitable genetic markers to improve these traits in breeding programs, many studies have Genome wide been conducted to map quantitative trait loci. Shortcomings of these studies were low mapping resolution, association large confidence intervals for quantitative trait loci-positions and large linkage disequilibrium blocks. Here, study we overcome these shortcomings by pooling four large F2 designs to produce smaller linkage Whole genome disequilibrium blocks and by resequencing the founder generation at high coverage and the F1 generation sequencing at low coverage for subsequent imputation of the F2 generation to whole genome sequencing marker Imputation density. This lead to the discovery of more than 32 million variants, 8 million of which have not been Meat previously reported. The pooling of the four F2 designs enabled us to perform a joint genome-wide carcass association study, which lead to the identification of numerous significantly associated variant clusters on and production chromosomes 1, 2, 4, 7, 17 and 18 for the growth and carcass traits average daily gain, back fat thickness, traits meat fat ratio, and carcass length.
    [Show full text]
  • Genome-Wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length
    ARTICLE Genome-wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length Chen Li,1,3,85 Svetlana Stoma,2,3,85 Luca A. Lotta,1,85 Sophie Warner,2,85 Eva Albrecht,4 Alessandra Allione,5,6 Pascal P. Arp,7 Linda Broer,7 Jessica L. Buxton,8,9 Alexessander Da Silva Couto Alves,10,11 Joris Deelen,12,13 Iryna O. Fedko,14 Scott D. Gordon,15 Tao Jiang,16 Robert Karlsson,17 Nicola Kerrison,1 Taylor K. Loe,18 Massimo Mangino,19,20 Yuri Milaneschi,21 Benjamin Miraglio,22 Natalia Pervjakova,23 Alessia Russo,5,6 Ida Surakka,22,24 Ashley van der Spek,25 Josine E. Verhoeven,21 Najaf Amin,25 Marian Beekman,13 Alexandra I. Blakemore,26,27 Federico Canzian,28 Stephen E. Hamby,2,3 Jouke-Jan Hottenga,14 Peter D. Jones,2 Pekka Jousilahti,29 Reedik Ma¨gi,23 Sarah E. Medland,15 Grant W. Montgomery,30 Dale R. Nyholt,15,31 Markus Perola,29,32 Kirsi H. Pietila¨inen,33,34 Veikko Salomaa,29 Elina Sillanpa¨a¨,22,35 H. Eka Suchiman,13 Diana van Heemst,36 Gonneke Willemsen,14 Antonio Agudo,37 Heiner Boeing,38 Dorret I. Boomsma,14 Maria-Dolores Chirlaque,39,40 Guy Fagherazzi,41,42 Pietro Ferrari,43 Paul Franks,44,45 Christian Gieger,4,46,47 Johan Gunnar Eriksson,48,49,50 Marc Gunter,43 Sara Ha¨gg,17 Iiris Hovatta,51,52 Liher Imaz,53,54 Jaakko Kaprio,22,55 Rudolf Kaaks,56 Timothy Key,57 (Author list continued on next page) Leukocyte telomere length (LTL) is a heritable biomarker of genomic aging.
    [Show full text]
  • Additional File 1: SDS-PAGE Fractionation with Silver Staining of Bone Marrow Supernatant from Six Β- Thalassemia/Hb E Patients (P) and Four Donors (D)
    Additional file 1: SDS-PAGE fractionation with silver staining of bone marrow supernatant from six β- thalassemia/Hb E patients (P) and four donors (D). Uniprot KB P1 P2 P3 P4 P5 P6 D1 D2 D3 D4 CU025_HUMAN 6.53 5.98 5.59 6.25 7.38 8.09 6.8 5.81 7.81 6.94 CUL3_HUMAN 0 0 7.6 3.56 5.69 0 11.01 0 0 0 CUL4B_HUMAN 8.61 8.11 8.56 9.46 9.54 7.4 9.26 9 9.57 10.67 CUX2_HUMAN 1.8 6.51 2.99 5.02 2.29 1.98 2.74 2.61 2.11 2.8 CWC22_HUMAN 8.36 8.89 8.05 8.62 8.13 8.77 9.12 8.74 8.06 8.59 CYB5_HUMAN 5.78 9.72 5.26 9.47 0 5.77 0 9.68 0 10 D19L2_HUMAN 0 0 0 0 4.94 0 6.18 0 0 8.56 DAZP2_HUMAN 0 7.1 3.54 3.88 0 0 3.79 3.96 5.3 8.73 DCA15_HUMAN 7.53 7.25 7.02 6.11 9.86 7.84 5.82 3.91 6.34 6.15 DCD2C_HUMAN 5.71 6.39 5.29 6.49 8.37 9.08 5.91 6.57 7.8 0 DCLK2_HUMAN 9.4 9.82 8.48 10.6 0 0 9.76 8.47 0 0 DDX_HUMAN 9.65 9.54 9.63 9.79 9.78 9.82 9.68 9.78 9.96 9.86 DDX5_HUMAN 8.48 8.65 9.79 8.16 8.11 8.3 8.25 8.09 8.46 8.16 DGCR8_HUMAN 7.82 8.93 10.83 6.47 9.7 11.78 9.64 12.25 9.57 8.36 DHH_HUMAN 8.08 8.14 8.49 8.48 8.16 8.5 8.13 8.22 8.09 8.48 DHX30_HUMAN 7.53 6.29 6.37 5.6 0 0 10.08 6.27 0 0 DHX8_HUMAN 11.9 12.02 12.07 11.92 12.06 12.07 12.07 12.06 12.07 12.03 DLGP2_HUMAN 13.5 0 0 0 13.73 13.72 0 13.72 13.72 13.72 DMXL2_HUMAN 0 0 0 2.97 4.72 6.18 0 4.59 6.91 7.03 DNA2_HUMAN 5.51 4.76 3.47 3.31 3.68 4.53 3.67 5.95 4.11 6.19 DPOD3_HUMAN 0 8.42 0 0 0 8.19 0 0 0 8.86 DPYL4_HUMAN 6.11 4.67 3.91 7.93 6.53 9.88 7.66 2.81 5.1 4.63 DSCL1_HUMAN 0 0 0 7.25 0 7.07 0 0 0 7.87 DUS8_HUMAN 7.32 7.12 7.05 8.17 6.9 7.19 7.45 7.78 6.52 7.17 DYH17_HUMAN 6.25 0 5.34 0 4.32 7.65 6.05
    [Show full text]
  • The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
    cancers Article The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer Ya-Sian Chang 1,2,3,4, Siang-Jyun Tu 2, Ju-Chen Yen 1, Ya-Ting Lee 1, Hsin-Yuan Fang 5 and Jan-Gowth Chang 1,2,3,6,7,* 1 Epigenome Research Center, China Medical University Hospital, Taichung 404332, Taiwan; [email protected] (Y.-S.C.); [email protected] (J.-C.Y.); [email protected] (Y.-T.L.) 2 Department of Laboratory Medicine, China Medical University Hospital, Taichung 404332, Taiwan; [email protected] 3 Center for Precision Medicine, China Medical University Hospital, Taichung 404332, Taiwan 4 Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404333, Taiwan 5 Department of Thoracic Surgery, China Medical University Hospital, Taichung 404332, Taiwan; [email protected] 6 School of Medicine, China Medical University, Taichung 404333, Taiwan 7 Department of Bioinformatics and Medical Engineering, Asia University, Taichung 41354, Taiwan * Correspondence: [email protected]; Tel.: +886-4-22052121 Simple Summary: Human cancer genomes show a variety of alterations, such as single base changes, deletions, insertions, copy number changes, and gene fusions. Analyzing fusion gene transcripts may yield a novel and effective approach for selecting cancer treatments. However, few comprehensive analyses of gene fusions in non-small cell lung cancer (NSCLC) patients have been performed. Here, we characterized the fusion gene landscape of NSCLC in a case study of Taiwanese lung cancer patients. We concluded that some fusion genes likely play driver roles in carcinogenesis, while others Citation: Chang, Y.-S.; Tu, S.-J.; Yen, act as passengers.
    [Show full text]
  • Identification of Potential and Novel Target Genes in Pituitary Prolactinoma by Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423732; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis 1 2 3 4* Vikrant Ghatnatti , Basavaraj Vastrad , Swetha Patil , Chanabasayya Vastrad , Iranna Kotturshetti5 1. Dept of Endocrinology/Medicine, J N Medical College, Belagavi 590010, Karnataka, India. 2. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 3. Dept of Obstetrics and Gynaecology, J N Medical college, Belagavi 590010, Karnataka, India. 4. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India. 5. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron 562209, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India Abstract bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423732; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Pituitary prolactinoma is one of the most complicated and fatally pathogenic pituitary adenomas. Therefore, there is an urgent need to improve our understanding of the underlying molecular mechanism that drives the initiation, progression, and metastasis of pituitary prolactinoma. The aim of the present study was to identify the key genes and signaling pathways associated with pituitary prolactinoma using bioinformatics analysis. Transcriptome microarray dataset GSE119063 was acquired from Gene Expression Omnibus datasets, which included 5 pituitary prolactinoma samples and 4 normal pituitaries samples.
    [Show full text]
  • Supplemental Section
    Supplemental section Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3 Tiangong Lu, Armand Bankhead III, Mats Ljungman, and Nouri Neamati Figure legends Figure S1: Generation of STAT3 KO ovarian cancer cell lines using CRISPR-Cas9 genome editing. Cells were transfected with 3 different STAT3 gRNAs, Cas9 nuclease mRNA and cleavage selection vectors. Flow cytometry analysis of OFP-positive cells showing percentages for each guide RNA in (A). SKOV3, (B). OVCAR3, OVCAR8 and HEY cells using guide RNAs for the STAT3 gene 72 hours post-transfection. STAT3 protein expression for each gRNA was detected by Western blot. (C). No STAT3 protein expression was detected in single cell cloned STAT3 KO ovarian cancer cells. NFC = normalized fold change. Figure S2: Characterization of STAT3 KO ovarian cancer cell lines. (A). Migration capability of WT and STAT3 KO cells was determined by a wound-healing assay. Bars from each cell line indicate wound area at 0h and 24h in percentage normalized to control. (B). Cell viability of spheroids at Days 2, 4 and 6 of WT and STAT3 KO cells in 3D spheroid assay. Luminescence representing cell viability was measured using the CellTiter-Glo® 3D Cell Viability Assay. Error bars indicate mean ± SEM. and **p < 0.01, ***p < 0.001. Figure S3: STAT3 KO inhibits tumor growth in mouse xenograft models. Image of tumors in nude mice (n = 5) injected with SKOV3, HEY, OVCAR3 and OVCAR8 WT/ STAT3 KO cells. Figure S4: Overlap of Gene Set Enrichment Analysis (GSEA) enriched gene sets for STAT3 knockout in three ovarian cancer cell lines (A) Common gene sets are listed with gene sets enriched in SKOV3 multi-omic analysis highlighted in bold.
    [Show full text]
  • Roman Umn 0130E 18396.Pdf (2.096Mb Application/Pdf)
    Pharmacogenetic Investigations Using Community-Based Participatory Research to Address Health Disparities in Minnesota Hmong A Dissertation SUBMITTED TO THE FACULTY OF UNIVERSITY OF MINNESOTA BY Joseph Malak Roman IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Adviser: Robert J Straka, Pharm.D., F.C.C.P. August 2017 © Joseph Malak Roman 2017 Acknowledgements This dissertation would not have been completed unless I had the support from a multitude of individuals from the Experimental and Clinical Pharmacology (ECP) Department and the College of Pharmacy at the University of Minnesota. First and foremost, I’m beyond grateful to my advisor, Dr. Robert Straka, for all his support, guidance and patience that he offered me throughout my training. Looking back on where I started and who I’m today, professionally, I realize that my career development was the result of continuous feedback and ongoing assessment of my work during the graduate school. I also want to thank Dr. Kathleen Culhane-Pera for being an outstanding community collaborator and support to my success. Indeed, she is an example to look up to when working with special and underserved communities. Finally, I want to thank the Hmong board members for their important role in making the university-community partnership very successful, the GOUT-H study volunteers, the study participants and the ECP faculty and staff. iii Dedication This dissertation is dedicated to my dad and grandmother whom I miss dearly. iv Abstract Introduction: Pharmacogenomics is an approach to personalizing therapy to help patients achieve their therapeutic goals with the least possible adverse events.
    [Show full text]
  • Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis
    Published OnlineFirst November 6, 2019; DOI: 10.1158/1541-7786.MCR-19-0722 MOLECULAR CANCER RESEARCH | CANCER GENES AND NETWORKS Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis Huan Wang1, Chao Wang2, Guang Peng2, Doudou Yu1, Xin-Gang Cui3,4, Ying-Hao Sun2, and Xiaojing Ma1,5 ABSTRACT ◥ Metastasis accounts for 90% of deaths caused by solid tumors, but protein, that are involved in actin cytoskeletal organization, which the multitude of mechanisms underlying tumor metastasis remains is required for cell polarization and focal adhesion formation. poorly understood. CARMIL1 and 2 proteins are capping protein Moreover, molecular pathway enrichment analysis reveals that lack (CP) interactants and multidomain regulators of actin-based mobil- of CARMIL3 leads to loss of cell adhesions and low CARMIL3 ity. However, CARMIL30s function has not been explored. Through expression in breast cancer patient specimens is implicated in bioinformatic metadata analysis, we find that high CARMIL3 epithelial–mesenchymal transition. We also find that CARMIL3 expression correlates with poor survival of patients with breast and sustains adherens junction between tumor cells. This is accom- prostate cancer. Functional studies in murine and xenograft tumor plished by CARMIL3 maintaining E-cadherin transcription down- models by targeted diminution of CARMIL3 expression or forced stream of HDACs through inhibiting ZEB2 protein level, also via expression demonstrate that CARMIL3 is vitally important for protecting b-catenin from ubiquitination-mediated degradation tumor metastasis, especially for metastatic colonization. Consistent initiated by the destruction complex. with a predominantly cell-intrinsic mode of action, CARMIL3 is also crucial for tumor cell migration and invasion in vitro.
    [Show full text]
  • Computational Methods for Studying Parent-Of-Origin Effects Via Reciprocal Mouse Crosses
    COMPUTATIONAL METHODS FOR STUDYING PARENT-OF-ORIGIN EFFECTS VIA RECIPROCAL MOUSE CROSSES Daniel G. Oreper A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in par- tial fulfillment of the requirements for the degree of Doctor of Philosophy in the Curriculum of Bioinformatics and Computational Biology Chapel Hill 2018 Approved by: Daniel Pomp Leonard McMillan Michael Love William Valdar Fernando Pardo-Manuel de Villena ©2018 Daniel G. Oreper ALL RIGHTS RESERVED ii ABSTRACT Daniel G. Oreper: Computational methods for studying parent-of-origin effects via reciprocal mouse crosses (Under the direction of William Valdar) Imprinted genes have been linked with diseases ranging from cancer, to metabolic syndromes, to psychiatric illness. For psychiatric illness in particular, numerous lines of evidence, both from human and mouse studies, suggest imprinted genes affect behavior along with brain development and function. Nonetheless, the effect of imprinted genes on most complex traits is not well characterized. Moreover, the architecture of environment-by-imprinting effects is even less well-understood. The lack of characterization is likely due to the general difficulty of observing “parent-of-origin effects” (POEs), which typically arise in mammals from maternal effects—or from imprinting. To study POE/environment-by-POE, we can employ a relatively neglected but maximally powerful POE- detection system: the reciprocal cross (RX). Towards this end, we develop and apply computational methods for designing and analyzing RX experiments. Here, these techniques are applied in the context of RXs of inbred lines of mice, with a focus on behavior—but these techniques could be similarly employed in any model organism subject to POE, and on any complex trait.
    [Show full text]